TP53 and melanoma: Treatment of melanoma cell lines with Tenovin-1, a SIRT1 inhibitor, resulted in decreased melanoma cell growth mediated by an increase in the tumor-suppressor P53 as well as the cyclin kinase inhibitor P21 (6).